Literature DB >> 22173708

Find and replace: editing human genome in pluripotent stem cells.

Huize Pan1, Weiqi Zhang, Weizhou Zhang, Guang-Hui Liu.   

Abstract

Genetic manipulation of human pluripotent stem cells (hPSCs) provides a powerful tool for modeling diseases and developing future medicine. Recently a number of independent genome-editing techniques were developed, including plasmid, bacterial artificial chromosome, adeno-associated virus vector, zinc finger nuclease, transcription activator-like effecter nuclease, and helper-dependent adenoviral vector. Gene editing has been successfully employed in different aspects of stem cell research such as gene correction, mutation knock-in, and establishment of reporter cell lines (Raya et al., 2009; Howden et al., 2011; Li et al., 2011; Liu et al., 2011b; Papapetrou et al., 2011; Sebastiano et al., 2011; Soldner et al., 2011; Zou et al., 2011a). These techniques combined with the utility of hPSCs will significantly influence the area of regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173708      PMCID: PMC4875250          DOI: 10.1007/s13238-011-1132-0

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  52 in total

1.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

2.  A method for genetic modification of human embryonic stem cells using electroporation.

Authors:  Magdaline Costa; Mirella Dottori; Koula Sourris; Pegah Jamshidi; Tanya Hatzistavrou; Richard Davis; Lisa Azzola; Steven Jackson; Sue Mei Lim; Martin Pera; Andrew G Elefanty; Edouard G Stanley
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.

Authors:  Jizhong Zou; Prashant Mali; Xiaosong Huang; Sarah N Dowey; Linzhao Cheng
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

4.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Guillermo Guenechea; Rita Vassena; Susana Navarro; María José Barrero; Antonella Consiglio; Maria Castellà; Paula Río; Eduard Sleep; Federico González; Gustavo Tiscornia; Elena Garreta; Trond Aasen; Anna Veiga; Inder M Verma; Jordi Surrallés; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

5.  Gene targeting in a HUES line of human embryonic stem cells via electroporation.

Authors:  Katherine M Ruby; Binhai Zheng
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

6.  Efficient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors.

Authors:  Chrishan J A Ramachandra; Mohammad Shahbazi; Timothy W X Kwang; Yukti Choudhury; Xiao Ying Bak; Jing Yang; Shu Wang
Journal:  Nucleic Acids Res       Date:  2011-06-17       Impact factor: 16.971

7.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.

Authors:  Tomas Cermak; Erin L Doyle; Michelle Christian; Li Wang; Yong Zhang; Clarice Schmidt; Joshua A Baller; Nikunj V Somia; Adam J Bogdanove; Daniel F Voytas
Journal:  Nucleic Acids Res       Date:  2011-04-14       Impact factor: 16.971

8.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.

Authors:  Kosuke Yusa; S Tamir Rashid; Helene Strick-Marchand; Ignacio Varela; Pei-Qi Liu; David E Paschon; Elena Miranda; Adriana Ordóñez; Nicholas R F Hannan; Foad J Rouhani; Sylvie Darche; Graeme Alexander; Stefan J Marciniak; Noemi Fusaki; Mamoru Hasegawa; Michael C Holmes; James P Di Santo; David A Lomas; Allan Bradley; Ludovic Vallier
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

9.  Genetic engineering of human pluripotent cells using TALE nucleases.

Authors:  Dirk Hockemeyer; Haoyi Wang; Samira Kiani; Christine S Lai; Qing Gao; John P Cassady; Gregory J Cost; Lei Zhang; Yolanda Santiago; Jeffrey C Miller; Bryan Zeitler; Jennifer M Cherone; Xiangdong Meng; Sarah J Hinkley; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2011-07-07       Impact factor: 54.908

10.  A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

Authors:  Claudio Mussolino; Robert Morbitzer; Fabienne Lütge; Nadine Dannemann; Thomas Lahaye; Toni Cathomen
Journal:  Nucleic Acids Res       Date:  2011-08-03       Impact factor: 16.971

View more
  10 in total

1.  Evolution of iPSC disease models.

Authors:  Weiqi Zhang; Zhichao Ding; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-01       Impact factor: 14.870

2.  Induced neural stem cells: a new tool for studying neural development and neurological disorders.

Authors:  Guang-Hui Liu; Fei Yi; Keiichiro Suzuki; Jing Qu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-05-01       Impact factor: 25.617

Review 3.  Converted neural cells: induced to a cure?

Authors:  Weiqi Zhang; Shunlei Duan; Ying Li; Xiuling Xu; Jing Qu; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-03-11       Impact factor: 14.870

4.  Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.

Authors:  Ioannis Papaioannou; J Paul Simons; James S Owen
Journal:  Cardiol Res Pract       Date:  2012-05-07       Impact factor: 1.866

Review 5.  Genomic editing tools to model human diseases with isogenic pluripotent stem cells.

Authors:  Huen Suk Kim; Jeffrey M Bernitz; Dung-Fang Lee; Ihor R Lemischka
Journal:  Stem Cells Dev       Date:  2014-10-07       Impact factor: 3.272

6.  CRISPR/Cas9 and TALE: beyond cut and paste.

Authors:  Liping Deng; Ruotong Ren; Jun Wu; Keiichiro Suzuki; Juan Carlos Izpisua Belmote; Guang-Hui Liu
Journal:  Protein Cell       Date:  2015-03       Impact factor: 14.870

7.  Stability of zinc finger nuclease protein is enhanced by the proteasome inhibitor MG132.

Authors:  Suresh Ramakrishna; Young-Hoon Kim; Hyongbum Kim
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 8.  Switching cell fate, ncRNAs coming to play.

Authors:  D Guan; W Zhang; W Zhang; G-H Liu; J C Izpisua Belmonte
Journal:  Cell Death Dis       Date:  2013-01-17       Impact factor: 8.469

9.  DICE, an efficient system for iterative genomic editing in human pluripotent stem cells.

Authors:  Fangfang Zhu; Matthew Gamboa; Alfonso P Farruggio; Simon Hippenmeyer; Bosiljka Tasic; Birgitt Schüle; Yanru Chen-Tsai; Michele P Calos
Journal:  Nucleic Acids Res       Date:  2013-12-04       Impact factor: 16.971

10.  SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2.

Authors:  Huize Pan; Di Guan; Xiaomeng Liu; Jingyi Li; Lixia Wang; Jun Wu; Junzhi Zhou; Weizhou Zhang; Ruotong Ren; Weiqi Zhang; Ying Li; Jiping Yang; Ying Hao; Tingting Yuan; Guohong Yuan; Hu Wang; Zhenyu Ju; Zhiyong Mao; Jian Li; Jing Qu; Fuchou Tang; Guang-Hui Liu
Journal:  Cell Res       Date:  2016-01-15       Impact factor: 25.617

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.